WHAT IS GLUCAGON-LIKE PEPTIDE-1 (GLP-1):
Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.
It is used as an antidiabetic medication used for the treatment of type 2 diabetes and long-term weight management.
It reduces food intake by lowering appetite and slowing down digestion in the stomach,helping to reduce body fat.
HOW TO USE:
Its half-life in the blood is about 7 days.
Dosages may vary between users, it’s recommended to start with a low dose and titrate until you reach and maintain the desired effects, dosages can range from 0.25 to 2.5 mg per week.
-
Incretin Mimetics
-
No
-
No
-
No
-
No
-
No
Add a Review
Your email address will not be published. Required fields are marked *
Submit a Photo
Your email address will not be published. Required fields are marked *